UK Spy Chief Warns of Moment of Consequence as West Faces Mounting Threats from Russia and China
Gilead Sciences GILD Ranked Among Wall Streets Most Profitable Stock Picks with 31 Net Margin and 24 Upside Potential
Oils Supply Crunch May Face Delays Amid Economic Uncertainty
Powell Vows to Avoid Shadow Chair Role as Potential Warsh Era Creates Historic Fed Dynamic
Oregons Gas Tax Defeat Political Fallout and Implications for Infrastructure Funding
Caribbean Property Rights Strain as Foreign Investment Reshapes Coastal Access
CF Industries Q1 2026 Earnings EPS Beats Expectations Amidst Stable Operations
BOBS Q1 2026 Earnings EPS Surges Past Estimates Shares Dip Despite Strong Beat
OCC Q1 2026 Earnings Narrowed Loss and Market Sentiment Boost Drive Stock Surge
908 Devices MASS Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher
BG Q1 2026 Earnings Earnings Surge 103 Above Estimates as Agribusiness Strength Outpaces Expectations
TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline
BioNTech BNTX Edges Higher Testing Key Technical Levels Amid Vaccine Market Shifts
DigitalBridge Group DBRG Holds Steady Near Support as Volume Signals Caution
Stardust Power SDST Gains 5 as Shares Test Key Resistance Levels
Restaurant Brands International QSR Dips 114 as Support Levels Come into Focus
Southside Bancshares SBSI Edges Lower Amid Quiet Trading Support Holds Near 3116
SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Dips
ACMR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher
bioAffinity Technologies BIAF Holds Near Support as Minimal Decline Reflects Cautious Trading
Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues
VEON Q1 2026 Earnings EPS Surpasses Estimates as Digital Transformation Gains Traction
CVNA Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies
CTSO Q1 2026 Earnings Loss Widens as EPS Misses Estimates Stock Gains 642
CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress
TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty
Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline